Biolidics Ltd
SGX:8YY
Biolidics Ltd
SGX:8YY
Price:
0.051
SGD
-5.56%
Market Closed
Market Cap:
S$88.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Biolidics Ltd
SGX:8YY
|
SG |
|
S
|
Swiftmerge Acquisition Corp
NASDAQ:IVCP
|
CA |
|
W
|
Weigang Environmental Technology Holding Group Ltd
HKEX:1845
|
CN |
|
S
|
Sasfin Holdings Ltd
XBER:47S
|
ZA |
|
Chang Wah Electromaterials Inc
TWSE:8070
|
TW |
Balance Sheet
Balance Sheet Decomposition
Biolidics Ltd
Biolidics Ltd
Balance Sheet Decomposition is not available for
Biolidics Ltd
Biolidics Ltd
Balance Sheet
Biolidics Ltd
Biolidics Ltd
Currency: SGD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
1
|
2
|
11
|
6
|
11
|
4
|
5
|
0
|
0
|
|
| Cash Equivalents |
3
|
1
|
2
|
11
|
6
|
11
|
4
|
5
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
4
|
3
|
4
|
13
|
8
|
13
|
6
|
6
|
0
|
1
|
|
| PP&E Net |
1
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
0
|
0
|
|
| Intangible Assets |
0
|
1
|
1
|
1
|
1
|
4
|
3
|
0
|
0
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
3
|
|
| Total Assets |
5
N/A
|
4
-31%
|
5
+40%
|
14
+173%
|
10
-32%
|
19
+95%
|
11
-39%
|
6
-47%
|
1
-89%
|
5
+587%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
6
|
4
|
10
|
1
|
1
|
1
|
1
|
5
|
1
|
1
|
|
| Total Current Liabilities |
6
|
4
|
11
|
2
|
1
|
2
|
2
|
6
|
2
|
2
|
|
| Long-Term Debt |
0
|
6
|
6
|
0
|
0
|
4
|
3
|
2
|
1
|
1
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
9
|
11
|
12
|
0
|
0
|
4
|
3
|
0
|
0
|
0
|
|
| Total Liabilities |
15
N/A
|
20
+33%
|
29
+42%
|
2
-94%
|
2
+14%
|
10
+465%
|
9
-13%
|
8
-14%
|
3
-66%
|
3
+10%
|
|
| Equity | |||||||||||
| Common Stock |
10
|
10
|
10
|
54
|
54
|
58
|
59
|
64
|
67
|
73
|
|
| Retained Earnings |
20
|
27
|
34
|
41
|
46
|
50
|
57
|
66
|
69
|
72
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
10
N/A
|
17
-67%
|
24
-43%
|
13
N/A
|
8
-38%
|
8
+7%
|
2
-72%
|
2
N/A
|
2
-18%
|
2
N/A
|
|
| Total Liabilities & Equity |
5
N/A
|
4
-31%
|
5
+40%
|
14
+173%
|
10
-32%
|
19
+95%
|
11
-39%
|
6
-47%
|
1
-89%
|
5
+587%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
243
|
256
|
256
|
256
|
256
|
279
|
280
|
493
|
658
|
1 555
|
|
Switch to:
Switch to:
See Also
Discover More
